Rapport Therapeutics Inc. Common Stock (RAPP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rapport Therapeutics Inc....

    NASDAQ: RAPP · Real-Time Price · USD
    28.54
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:59 PM
    29.00
    1.61%
    Pre-market: Oct 06, 2025, 05:51 AM EDT

    Rapport Therapeutics Common Stock Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    PE Ratio
    		 -46.98 -108.1 -392.82
    PEG Ratio
    		 -0.47 -0.42 n/a
    PS Ratio
    		 n/a n/a n/a
    PB Ratio
    		 12.05 26.68 214.53
    P/FCF Ratio
    		 -54.72 -130.49 -1.19K
    P/OCF Ratio
    		 -56.75 -138.35 -1.29K
    OCF/S Ratio
    		 n/a n/a n/a
    Debt / Equity Ratio
    		 0.00 0.02 0.53
    Quick Ratio
    		 35.34 17.14 18.80
    Current Ratio
    		 35.34 17.14 18.80
    Asset Turnover
    		 n/a n/a n/a
    Interest Coverage
    		 n/a n/a -36.38
    Return on Equity
    		 -0.26 -0.25 -0.55
    Return on Assets
    		 -0.25 -0.22 -0.34
    Return on Invested Capital
    		 -0.27 -0.24 -0.35
    Dividend Yield
    		 n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a

    Add to Watchlist